Optiver Holding’s Anavex Life Sciences AVXL Stock Holding History

Optiver Holding’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-204	Closed	-$1.82K	–	2501
2025 Q3	$1.82K	Buy	+204	New	+$2.07K	﹤0.01%	2411

Other funds holding AVXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Optiver Holding's AVXL Position: Q4 2025 in Review

Optiver Holding sold out of Anavex Life Sciences (AVXL) in Q4 2025, closing a stake of 204 shares — an estimated $1.82K sold.

Optiver Holding first reported a position in AVXL in Q3 2025 and held it in 1 quarter. The position peaked at $1.82K in Q3 2025. 183 funds tracked by Wall St. Rank hold AVXL as of Q4 2025.

Optiver Holding reported no remaining Anavex Life Sciences position as of Q4 2025 after selling out during the quarter.
Optiver Holding sold 204 Anavex Life Sciences shares in Q4 2025, an estimated $1.82K.
Optiver Holding first reported a position in Anavex Life Sciences in Q3 2025 and held it in 1 quarter.
Optiver Holding's Anavex Life Sciences position peaked at $1.82K in Q3 2025.
183 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q4 2025.

Based on Optiver Holding's 13F filing for Q4 2025, filed 17 Feb 2026.